Complications associated with an IVC filter may include fracture, migration, perforation of the inferior vena cava or vital organs, internal bleeding, and death. The risk of complications increases if a retrievable IVC filter is not removed once the patient is no longer at risk for a pulmonary embolism.
Patients who have suffered IVC filter complications allegedly related to the use of certain devices manufactured by C.R. Bard, Inc. or Cook Medical, Inc. may be entitled to compensation from these companies. To learn if you qualify to file an IVC filter lawsuit, please call the nationwide law firm of Bernstein Liebhard LLP at (888) 994-5118 to arrange for a free, no-obligation review of your case.
IVC filter are used in patients at risk for pulmonary embolism, but who are not able to use standard blood thinning drugs. Retrievable IVC filter are intended for temporary placement, and should be removed once the patient is out of danger. Some common IVC filter brands include:
An IVC filter is implanted into the inferior vena cava, which is the body’s largest blood vessel. It carries blood from lower extremities to the right atrium of the heart and then to the lungs. Once an IVC filter is in place, it will catch any clots that form in the lower extremities before they can travel to the lungs and become a pulmonary embolism.
Possible complications associated with a retrievable IVC filter include:
In 2010, the FDA issued the first of two alerts that focused on the risks associated with IVC filters. Among other things, the agency disclosed that it had received more than 900 reports of IVC filter complications, some of which resulted in adverse patient outcomes. These incidents included:
The FDA was concerned that many of the reported incidents occurred because retrievable IVC filter were not removed once a patient no longer had a need for the devices.
In 2014, the agency issued its second IVC filter alert, and reminded doctors about the importance of retrieving filters meant for temporary placement “For patients with retrievable filters, some complications may be avoided if the filter can be removed once the risk of pulmonary embolism has subsided,” the alert stated.
A study published in a March 2016 issue of JACC: Cardiovascular Interventions suggested that an increase in IVC thrombosis may be linked to untretrieved IVC filters. These dangerous blood clots account for 2.6% to 4.0% of all deep venous thrombosis cases. However, the authors of the report warned that the true incidence may be underestimated, due in part to the exponential increase in the number of unretrieved IVC filters among U.S. patients. Read More
Bernstein Liebhard LLP is now offering free, no-obligation legal reviews to individuals who may have experienced serious complications due to a retrievable IVC filter. To learn more about your available legal options, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.